Pennington Biomedical researchers are preparing to head to Atlanta for ObesityWeek 2025 , presented by The Obesity Society, or TOS. Taking place Nov. 4-7, ObesityWeek is the preeminent international conference for obesity researchers and clinicians, featuring the latest developments in evidence-based obesity science.
Pennington Biomedical will be well represented at the conference, as faculty members are not just participating in but are among the 250 experts leading courses, presentations and speaker panels during the event.
“With nearly 40 years of obesity research, Pennington Biomedical continues to lead the way in advancing treatment modalities across lifestyle interventions, pharmacology, and surgery,” said Dr. John Kirwan, Executive Director of Pennington Biomedical. “Our comprehensive approach and the breadth of expertise among our faculty, postdoctoral fellows, and staff position us uniquely to address the obesity epidemic from multiple angles. We’re honored that so many of our researchers are leading discussions at ObesityWeek, and we look forward to sharing our latest findings with colleagues from around the world.”
Pennington Biomedical researchers will participate in numerous panels and presentations during the conference, including:
Additionally, Dr. Robert Dubin, Dr. Allerton and Dr. Apolzan will serve as session chairs for various panel discussions, while Dr. Jackie Stephens will present awards during the Young Investigators Awards Competition, of which Dr. Florina Corpodean is competing. A number of researchers will also present their findings during the various poster sessions during the conference.
ObesityWeek is home to the latest developments in evidence-based obesity science: cutting-edge basic and clinical research, state-of-the-art obesity treatment and prevention, and the latest efforts in advocacy and public policy. Treating obesity requires multi-disciplinary approaches. This is the conference that encompasses the full spectrum of obesity science: from basic science research, to translational research and clinical application, to public policy; from diet, exercise, lifestyle, and psychology to medical and surgical interventions; from pediatric to geriatric to underserved populations.
About the Pennington Biomedical Research Center
The Pennington Biomedical Research Center is at the forefront of medical discovery as it relates to understanding the triggers of obesity, diabetes, cardiovascular disease, cancer and dementia. Pennington Biomedical has the vision to lead the world in promoting nutrition, metabolic health and eliminating metabolic disease through scientific discoveries that create solutions from cells to society. The Center conducts basic, clinical, and population research, and is a campus in the LSU System.
The research enterprise at Pennington Biomedical includes over 600 employees within a network of 44 clinics and research laboratories, and 16 highly specialized core service facilities. Its scientists and physician/scientists are supported by research trainees, lab technicians, nurses, dietitians, and other support personnel. Pennington Biomedical is a globally recognized state-of-the-art research institution in Baton Rouge, Louisiana. For more information, see www.pbrc.edu .